The understanding of the role of metal ions in blood coagulation has been a long term goal of this laboratory. To further the understanding of the structure-function relationships of the Gamma-carboxyglutamic acid residues in prothrombin to the metal liganding processes of the protein we will study a naturally occurring variant of prothrombin which contains only three Gamma-carboxyglutamic acid residues. Normal prothrombin contains ten Gamma-carboxyglutamic acid residues. We will correlate the sequence position of the Gamma-carboxyglutamic acid residues in the variant with its metal binding and conformational properties using amino acid sequence analysis, state rate dialysis, fluorescence spectroscopy and conformation specific antibodies. The results of these analyses will be used to compare and contrast the properties of normal prothrombin and the variant prothrombin. Platelets secrete Ca(II) upon activation. There is potential for a significant increase in Ca(II) concentration at the site of platelet plug formation. In addition, Ca(II) dependent conversion of several plasma zymogens may occur on the platelet surface. We will use monoclonal conformation specific antibodies to identify platelet surface antigens whose conformations are altered depending on the presence or absence of metal ligands. We will correlate the presence of the antigen to the status of the platelet (native or activated). We will identify a possible receptor function for the platelet surface antigens recognized by these monoclonal antibodies. Finally we have identified a novel cleavage product of human prothrombin in plasma, fragment 1.2.3. We will access a potential regulatory role for this fragment in hemostasis. There is currently heightened interest in understanding the processes that regulate hemostasis and thrombosis. The studies outlined in this proposal address these biologically interesting and medically important questions.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL018834-16
Application #
3485595
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1978-06-01
Project End
1993-05-31
Budget Start
1990-06-01
Budget End
1991-05-31
Support Year
16
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02111
Falls, L A; Furie, B C; Jacobs, M et al. (2001) The omega-loop region of the human prothrombin gamma-carboxyglutamic acid domain penetrates anionic phospholipid membranes. J Biol Chem 276:23895-902
Falls, L A; Furie, B; Furie, B C (2000) Role of phosphatidylethanolamine in assembly and function of the factor IXa-factor VIIIa complex on membrane surfaces. Biochemistry 39:13216-22
Blostein, M D; Rigby, A C; Jacobs, M et al. (2000) The Gla domain of human prothrombin has a binding site for factor Va. J Biol Chem 275:38120-6
Bush, K A; Stenflo, J; Roth, D A et al. (1999) Hydrophobic amino acids define the carboxylation recognition site in the precursor of the gamma-carboxyglutamic-acid-containing conotoxin epsilon-TxIX from the marine cone snail Conus textile. Biochemistry 38:14660-6
Furie, B; Bouchard, B A; Furie, B C (1999) Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood 93:1798-808
Gillis, S; Furie, B C; Furie, B et al. (1997) gamma-Carboxyglutamic acids 36 and 40 do not contribute to human factor IX function. Protein Sci 6:185-96
Furie, B C; Ratcliffe, J V; Tward, J et al. (1997) The gamma-carboxylation recognition site is sufficient to direct vitamin K-dependent carboxylation on an adjacent glutamate-rich region of thrombin in a propeptide-thrombin chimera. J Biol Chem 272:28258-62
Rigby, A C; Baleja, J D; Li, L et al. (1997) Role of gamma-carboxyglutamic acid in the calcium-induced structural transition of conantokin G, a conotoxin from the marine snail Conus geographus. Biochemistry 36:15677-84
Kotkow, K J; Deitcher, S R; Furie, B et al. (1995) The second kringle domain of prothrombin promotes factor Va-mediated prothrombin activation by prothrombinase. J Biol Chem 270:4551-7
Bristol, J A; Freedman, S J; Furie, B C et al. (1994) Profactor IX: the propeptide inhibits binding to membrane surfaces and activation by factor XIa. Biochemistry 33:14136-43

Showing the most recent 10 out of 39 publications